Company intelligence / Profile preview

Nayan Therapeutics

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Nayan Therapeutics developed small molecule therapies targeting rod degeneration in inherited retinal diseases to preserve cone function; no clinical-stage results available and company is now dissolved

Therapeutic areas: Ophthalmology
Modalities: Small molecule
Industry: Biotech

Partnerships

Retinal Degeneration Fund (portfolio company)

Beyond the preview

Go deeper on Nayan Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nayan Therapeutics.

Explore the full profile